Wednesday brought a quiet day in the major indices—the S&P 500 edged down 0.47% to 747.71—but the tape underneath was anything but sleepy. Biotech and penny stocks staged outsized moves, suggesting rotation out of blue-chip tech into riskier corners of the market. Meanwhile, the Nasdaq 100 and other large-cap benchmarks are MIA from the data stream, leaving us flying half-blind.
Market movers
|
S&P 500
747.71
-0.48%
|
Nasdaq 100
—
—
|
Dow Jones
—
—
|
Russell 2000
—
—
|
Volatility
—
—
|
| CRNX | Crinetics Pharmaceuticals, Inc. | 83.53 | +98.74% |
| CLRO | ClearOne, Inc. | 13.84 | +97.71% |
| TVRD | Tvardi Therapeutics, Inc. | 3.10 | +54.23% |
| SKIN | The Beauty Health Company | 1.11 | +47.04% |
| AKTX | Akari Therapeutics, Plc | 15.48 | +42.02% |
| RVNL | GraniteShares 2x Long RIVN Daily ETF | 27.87 | -36.85% |
| WFF | WF Holding Limited | 2.03 | -31.65% |
| KIDZ | KIDZ AI Inc. | 0.74 | -29.90% |
| ARCLR | ARC Group Acquisition I Corp Right | 0.17 | -28.45% |
| HODO | Brag House Holdings, Inc. | 1.78 | -27.05% |
CRNX nearly doubled on what appears to be biotech momentum, while CLRO and TVRD posted triple-digit and 54% gains respectively. On the flip side, RVNL (a 2x long Rivian play) got hammered for 37%, and a handful of micro-cap and blank-check vehicles cratered. The broad market's mild decline masks a flight to extremes: risk-on in small speculative names, risk-off in leveraged single-stock bets.
The Daily Dollar is auto-generated for informational and educational purposes only. Nothing here is financial advice, a recommendation to buy or sell, or a forecast. Markets are risky; do your own research.